Abstract:ObjectiveRecent advances in next-generation sequencing (NGS) have provided new methods for preimplantation genetic screening (PGS) of human embryos from IVF cycles. The present study aimed to investigate the effects of NGS screening on clinical pregnancy and ongoing pregnancy outcomes of single embryo transfer for PGS patients in comparison to array comparative genomic hybridization (aCGH) screening.DesignA total of 131 PGS patients at mean age 35.6 ± 3.4 years (ranging 28 to 39 years old) who met the inclusion criteria were randomized into two groups: 1) NGS (Group A): patients (n=66) had embryos screened with NGS and 2) aCGH (Group B): patients (n=65) had embryos screened with aCGH. The cohort patients requested PGS due to recurrent pregnancy loss (n=59), repeated implantation failure (n=48) and previous aneuploid conceptions (n=24).Materials and MethodsFor both NGS and aCGH groups, embryos were cultured to blastocyst stage and trophectoderm biopsy was performed on Day 5 (up to 11:00 pm). Blastocysts were vitrified individually after biopsy. One euploid blastocyst was transferred to individual patients based on the results of PGS with either NGS (Group A) or aCGH (Group B). Clinical pregnancy and ongoing pregnancy rates per transfer were compared between the two groups. Clinical pregnancy was defined as an intrauterine gestational sac with fetal heartbeat visualized by ultrasound examination at week 8 after embryo transfer. Ongoing pregnancy was defined as continuing pregnancy at ≥ 20 weeks of gestation. The categorical variables were analyzed by Chi-square analysis or Fisher’s exact test as appropriate. A two-tailed value of p <0.05 was considered statistically significant.ResultsThere were no significant differences in female patient’s mean age, Day 3 FSH, AMH, E2, antral follicle number between the two groups (p >0.05). NGS screening identified single euploid blastocysts for transfer and resulted in similar clinical pregnancy rates for PGS patients compared to aCGH screening (69.8% vs. 65.6%, respectively, p >0.05). There was no significant difference in ongoing pregnancy rates between the NGS and aCGH groups (68.3% vs. 63.9%, respectively, p >0.05). The miscarriage rates were also comparable between Group A and Group B (1.5% vs. 1.6%, respectively, p >0.05).ConclusionsWhile NGS screening has been recently introduced to assist IVF patients, this is the first randomized clinical study on the efficiency of NGS for single embryo transfer in comparison to aCGH. With the observed high accuracy of 24-chromosome screening and the resulting high clinical pregnancy and ongoing pregnancy rates, NGS has demonstrated an efficient, robust high-throughput technology for selection of single embryo for transfer. ObjectiveRecent advances in next-generation sequencing (NGS) have provided new methods for preimplantation genetic screening (PGS) of human embryos from IVF cycles. The present study aimed to investigate the effects of NGS screening on clinical pregnancy and ongoing pregnancy outcomes of single embryo transfer for PGS patients in comparison to array comparative genomic hybridization (aCGH) screening. Recent advances in next-generation sequencing (NGS) have provided new methods for preimplantation genetic screening (PGS) of human embryos from IVF cycles. The present study aimed to investigate the effects of NGS screening on clinical pregnancy and ongoing pregnancy outcomes of single embryo transfer for PGS patients in comparison to array comparative genomic hybridization (aCGH) screening. DesignA total of 131 PGS patients at mean age 35.6 ± 3.4 years (ranging 28 to 39 years old) who met the inclusion criteria were randomized into two groups: 1) NGS (Group A): patients (n=66) had embryos screened with NGS and 2) aCGH (Group B): patients (n=65) had embryos screened with aCGH. The cohort patients requested PGS due to recurrent pregnancy loss (n=59), repeated implantation failure (n=48) and previous aneuploid conceptions (n=24). A total of 131 PGS patients at mean age 35.6 ± 3.4 years (ranging 28 to 39 years old) who met the inclusion criteria were randomized into two groups: 1) NGS (Group A): patients (n=66) had embryos screened with NGS and 2) aCGH (Group B): patients (n=65) had embryos screened with aCGH. The cohort patients requested PGS due to recurrent pregnancy loss (n=59), repeated implantation failure (n=48) and previous aneuploid conceptions (n=24). Materials and MethodsFor both NGS and aCGH groups, embryos were cultured to blastocyst stage and trophectoderm biopsy was performed on Day 5 (up to 11:00 pm). Blastocysts were vitrified individually after biopsy. One euploid blastocyst was transferred to individual patients based on the results of PGS with either NGS (Group A) or aCGH (Group B). Clinical pregnancy and ongoing pregnancy rates per transfer were compared between the two groups. Clinical pregnancy was defined as an intrauterine gestational sac with fetal heartbeat visualized by ultrasound examination at week 8 after embryo transfer. Ongoing pregnancy was defined as continuing pregnancy at ≥ 20 weeks of gestation. The categorical variables were analyzed by Chi-square analysis or Fisher’s exact test as appropriate. A two-tailed value of p <0.05 was considered statistically significant. For both NGS and aCGH groups, embryos were cultured to blastocyst stage and trophectoderm biopsy was performed on Day 5 (up to 11:00 pm). Blastocysts were vitrified individually after biopsy. One euploid blastocyst was transferred to individual patients based on the results of PGS with either NGS (Group A) or aCGH (Group B). Clinical pregnancy and ongoing pregnancy rates per transfer were compared between the two groups. Clinical pregnancy was defined as an intrauterine gestational sac with fetal heartbeat visualized by ultrasound examination at week 8 after embryo transfer. Ongoing pregnancy was defined as continuing pregnancy at ≥ 20 weeks of gestation. The categorical variables were analyzed by Chi-square analysis or Fisher’s exact test as appropriate. A two-tailed value of p <0.05 was considered statistically significant. ResultsThere were no significant differences in female patient’s mean age, Day 3 FSH, AMH, E2, antral follicle number between the two groups (p >0.05). NGS screening identified single euploid blastocysts for transfer and resulted in similar clinical pregnancy rates for PGS patients compared to aCGH screening (69.8% vs. 65.6%, respectively, p >0.05). There was no significant difference in ongoing pregnancy rates between the NGS and aCGH groups (68.3% vs. 63.9%, respectively, p >0.05). The miscarriage rates were also comparable between Group A and Group B (1.5% vs. 1.6%, respectively, p >0.05). There were no significant differences in female patient’s mean age, Day 3 FSH, AMH, E2, antral follicle number between the two groups (p >0.05). NGS screening identified single euploid blastocysts for transfer and resulted in similar clinical pregnancy rates for PGS patients compared to aCGH screening (69.8% vs. 65.6%, respectively, p >0.05). There was no significant difference in ongoing pregnancy rates between the NGS and aCGH groups (68.3% vs. 63.9%, respectively, p >0.05). The miscarriage rates were also comparable between Group A and Group B (1.5% vs. 1.6%, respectively, p >0.05). ConclusionsWhile NGS screening has been recently introduced to assist IVF patients, this is the first randomized clinical study on the efficiency of NGS for single embryo transfer in comparison to aCGH. With the observed high accuracy of 24-chromosome screening and the resulting high clinical pregnancy and ongoing pregnancy rates, NGS has demonstrated an efficient, robust high-throughput technology for selection of single embryo for transfer. While NGS screening has been recently introduced to assist IVF patients, this is the first randomized clinical study on the efficiency of NGS for single embryo transfer in comparison to aCGH. With the observed high accuracy of 24-chromosome screening and the resulting high clinical pregnancy and ongoing pregnancy rates, NGS has demonstrated an efficient, robust high-throughput technology for selection of single embryo for transfer.

Selection of Single Blastocysts for Transfer Via Time-Lapse Monitoring Alone and with Next-Generation Sequencing to Reduce Multiple Pregnancies: A Randomized Pilot Study.

Frozen Versus Fresh Single Blastocyst Transfer in Ovulatory Women: a Multicentre, Randomised Controlled Trial.

Predictive Value of the Number of Frozen Blastocysts in Live Birth Rates of the Transferred Fresh Embryos

Live Birth after Fresh Versus Frozen Single Blastocyst Transfer (Frefro-Blastocyst): Study Protocol for a Randomized Controlled Trial

Selection of Competent Blastocysts for Transfer by Combining Time-Lapse Monitoring and Array CGH Testing for Patients Undergoing Preimplantation Genetic Screening: a Prospective Study with Sibling Oocytes

Selecting single euploid blastocysts for transfer with NGS significantly improves IVF treatment outcomes: a randomized study

The Combined Use of Time-Lapse and Next-Generation Sequencing Improves Clinical Outcomes: Results from a Randomized Pilot Study

Effect of single blastocyst-stage versus single cleavage-stage embryo transfer on cumulative live births in women with good prognosis undergoing in vitro fertilization: Multicenter Randomized Controlled Trial

Can Time-Lapse Incubation and Monitoring Be Beneficial to Assisted Reproduction Technology Outcomes? A Randomized Controlled Trial Using Day 3 Double Embryo Transfer

Time-lapse and Ngs Evaluation of Morphokinetics, Ploidy and Clinical Outcome of Human Embryos Cultured in Continuous Single Culture Medium Versus Sequential Culture Medium: a Randomized Pilot Study

Single Embryo Transfer by Day 3 Time-Lapse Selection Versus Day 5 Conventional Morphological Selection: a Randomized, Open-Label, Non-Inferiority Trial

Live Birth with or without Preimplantation Genetic Testing for Aneuploidy

Selection of Euploid Blastocysts for Cryopreservation with Array Comparative Genomic Hybridization (acgh) Results in Increased Implantation Rates in Subsequent Frozen and Thawed Embryo Transfer Cycles

Non-invasive Embryo Selection Strategy for Clinical IVF to Avoid Wastage of Potentially Competent Embryos

A pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencing

Effect of Noninvasive Embryo Viability Testing Versus Conventional IVF on the Live Birth Rate in IVF/ICSI Patients: a Study Protocol for a Double-Blind, Multicenter, Randomized Controlled Trial.

Preimplantation Genetic Testing for Aneuploidy Could Not Improve Cumulative Live Birth Rate among 705 Couples with Unexplained Recurrent Implantation Failure

Selection of Single Euploid Blastocysts for Transfer Via Preimplantation Genetic Screening with Either Next-Generation Sequencing or Array Comparative Genomic Hybridization: a Randomized Pilot Study

Pregnancy outcomes of single/double blastocysts and cleavage embryo transfers: A retrospective cohort study of 24422 frozen-thawed cycles

Comparative Analysis of Pregnancy Outcomes in Preimplantation Genetic Testing for Aneuploidy and Conventional in Vitro Fertilization and Embryo Transfer: a Stratified Examination on the Basis of the Quantity of Oocytes and Blastocysts from a Multicenter Randomized Controlled Trial.

Application of Two Blastocyst Biopsy Strategies in Preimplantation Genetic Testing Treatment and Assessment of Their Effects